Drug Approval | March 06, 2023
Zydus receives final approval from the USFDA for Vigabatrin for Oral Solution
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
New workflow integrates the xCELLigence RTCA HT with the BioTek BioSpa 8 Automated Incubator
IAGES to focus on upskilling and adoption of advanced Minimal Access Surgery technologies in 2023
Strategic partnership aims to support significant growth of the Ibuprofen product market in Brazil and is backed by Univar Solutions' state-of-the-art Solution Center in São Paulo, Brazil
For discovery or for standardization, Ayurveda colleges/institutes need to collaborate closely with Phytochemists, Pharmacologists, and Toxicologists from premier institutions
The initiative launched in 2019 has touched over 10,000 lives with 500+ screening camps and aims to double its reach in the next 2 years
Subscribe To Our Newsletter & Stay Updated
